Hi-tech brain implant trial gives hope to Parkinson`s disease sufferers
London: Scientists have claimed that a hi-tech brain implant could transform the lives of people living with Parkinson's disease.
Scientists in Bristol have developed a system of tubes and catheters that allows them to pump protein therapy deep into patients' brains.
It is hoped the technique will encourage cells damaged by the disease to grow again.
The protein, known as glial cell line-derived neurotrophic factor (GDNF), is injected once a month through a port just behind the ear and pushed through the tubes and catheters by an external pump.
Doctors at Frenchay Hospital, Bristol, have trialled the system on six patients and are now looking for another 36 to continue the research.
"For years, the potential of GDNF as a treatment for Parkinson's has remained one of the great unanswered research questions," Dr Kieran Breen, director of research and innovation at Parkinson's UK, said.
"This new study will take us one step closer to finally answering this question once and for all.
"We believe GDNF could have the potential to unlock a new approach for treating Parkinson's that may be able to slow down and ultimately stop the progression of the condition all together," Breen said.
More from India
More from World
More from Sports
More from Entertaiment
- Dr Subhash Chandra Show: How to develop good communication skills for a successful life?
- Curfew lifted from 4 districts of Kashmir valley
- Recently launched Pokemon Go gaining extreme popularity among users
- Rajnath Singh meets J&K CM Mehbooba Mufti to discuss current situation in valley
- AAP MLA Amantulla Khan arrested for misbehaving with a woman
- Three Taliban commanders arrested in Afghanistan's Samangan province
- Kamal Haasan still under medical care in hospital
- Kashmir unrest: Policeman injured in Burhan Wani protest dies, death toll rises to 46
- PNB Housing Finance readies Rs 2,500-crore IPO, heads to tier 2, 3 cities
- Guess which state has max urban net subscribers; Maha, Delhi tied in 2nd spot